Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,559,259
+$363,558 QoQ
Shares Held
1,300
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#2,734
of 4,604 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Harbor Advisors LLC holds $2,581,583 across 3 Drug Manufacturers - General names. LLY ranks #1 (60.4% of the industry book) .
All Filings in LLY
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,559,259 | 1,300 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $1,195,701 | 1,300 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $967,212 | 900 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $686,700 | 900 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $701,577 | 900 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $743,319 | 900 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $694,800 | 900 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $797,346 | 900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $814,842 | 900 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $700,164 | 900 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $291,460 | 500 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $268,565 | 500 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $234,490 | 500 | Shares | Sole | 2023-08-15 | |
| No filing history on record for this holder in this stock. | ||||||